Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Malignant Lymphoma

Free Subscription Articles published in Oncogene Retrieve available abstracts of 49 articles: HTML format

Single Articles

March 2008
1. WANG P , Lushnikova T, Odvody J, Greiner TC, et al
   Elevated Mdm2 expression induces chromosomal instability and confers a survival and growth advantage to B cells.
   Oncogene. 2008;27:1590-8.
   PubMed     Related articles    Abstract available
   
   
   February 2008
2. ENGELMANN A , Speidel D, Bornkamm GW, Deppert W, et al
   Gadd45 beta is a pro-survival factor associated with stress-resistant tumors.
   Oncogene. 2008;27:1429-38.
   PubMed     Related articles    Abstract available
   
   
   
3. RAINEY MD , Black EJ, Zachos G, Gillespie DA, et al
   Chk2 is required for optimal mitotic delay in response to irradiation-induced DNA damage incurred in G2 phase.
   Oncogene. 2008;27:896-906.
   PubMed     Related articles    Abstract available
   
   
   January 2008
4. CLYBOUW C , E L McHichi B, Hadji A, Portier A, et al
   TGFbeta-mediated apoptosis of Burkitt's lymphoma BL41 cells is associated with the relocation of mitochondrial BimEL.
   Oncogene. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
5. TAKEYAMA K , Monti S, Manis JP, Cin PD, et al
   Integrative analysis reveals 53BP1 copy loss and decreased expression in a subset of human diffuse large B-cell lymphomas.
   Oncogene. 2008;27:318-22.
   PubMed     Related articles    Abstract available
   
   
   
6. HOWARD G , Eiges R, Gaudet F, Jaenisch R, et al
   Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice.
   Oncogene. 2008;27:404-8.
   PubMed     Related articles    Abstract available
   
   
   November 2007
7. STOCKLEIN H , Smardova J, Macak J, Katzenberger T, et al
   Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphoma.
   Oncogene. 2007;.
   PubMed     Related articles    Abstract available
   
   
   October 2007
8. LIN YC , Diccianni MB, Kim Y, Lin HH, et al
   Human p16gamma, a novel transcriptional variant of p16(INK4A), coexpresses with p16(INK4A) in cancer cells and inhibits cell-cycle progression.
   Oncogene. 2007;26:7017-27.
   PubMed     Related articles    Abstract available
   
   
   September 2007
9. XIAO W , Zhang Q, Habermacher G, Yang X, et al
   U19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasia.
   Oncogene. 2007;.
   PubMed     Related articles    Abstract available
   
   
   
10. SUZUKI E , Umezawa K, Bonavida B
    Rituximab inhibits the constitutively activated PI3K-Akt pathway in B-NHL cell lines: involvement in chemosensitization to drug-induced apoptosis.
    Oncogene. 2007;26:6184-93.
    PubMed     Related articles    Abstract available
    
    
    
11. WOO Y , Wright SM, Maas SA, Alley TL, et al
    The nonhomologous end joining factor Artemis suppresses multi-tissue tumor formation and prevents loss of heterozygosity.
    Oncogene. 2007;26:6010-20.
    PubMed     Related articles    Abstract available
    
    
    August 2007
12. BRIEN G , Trescol-Biemont MC, Bonnefoy-Berard N
    Downregulation of Bfl-1 protein expression sensitizes malignant B cells to apoptosis.
    Oncogene. 2007;26:5828-32.
    PubMed     Related articles    Abstract available
    
    
    
13. MARZEC M , Kasprzycka M, Liu X, El-Salem M, et al
    Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.
    Oncogene. 2007;26:5606-14.
    PubMed     Related articles    Abstract available
    
    
    
14. OHI H , Mishima Y, Kamimura K, Maruyama M, et al
    Multi-step lymphomagenesis deduced from DNA changes in thymic lymphomas and atrophic thymuses at various times after gamma-irradiation.
    Oncogene. 2007;26:5280-9.
    PubMed     Related articles    Abstract available
    
    
    
15. MIN JN , Huang L, Zimonjic DB, Moskophidis D, et al
    Selective suppression of lymphomas by functional loss of Hsf1 in a p53-deficient mouse model for spontaneous tumors.
    Oncogene. 2007;26:5086-97.
    PubMed     Related articles    Abstract available
    
    
    July 2007
16. HAUSHERR A , Tavares R, Schaffer M, Obermeier A, et al
    Inhibition of IL-6-dependent growth of myeloma cells by an acidic peptide repressing the gp130-mediated activation of Src family kinases.
    Oncogene. 2007;26:4987-98.
    PubMed     Related articles    Abstract available
    
    
    
17. ANDERTON E , Yee J, Smith P, Crook T, et al
    Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    June 2007
18. DAWSON DW , Hong JS, Shen RR, French SW, et al
    Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas.
    Oncogene. 2007;26:4243-52.
    PubMed     Related articles    Abstract available
    
    
    May 2007
19. GRABARCZYK P , Przybylski GK, Depke M, Volker U, et al
    Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells.
    Oncogene. 2007;26:3797-810.
    PubMed     Related articles    Abstract available
    
    
    
20. WALDMANN TA
    Daclizumab (anti-Tac, Zenapax) in the treatment of leukemia/lymphoma.
    Oncogene. 2007;26:3699-703.
    PubMed     Related articles    Abstract available
    
    
    
21. DAVIES AJ
    Radioimmunotherapy for B-cell lymphoma: Y(90) ibritumomab tiuxetan and I(131) tositumomab.
    Oncogene. 2007;26:3614-28.
    PubMed     Related articles    Abstract available
    
    
    
22. COIFFIER B
    Rituximab therapy in malignant lymphoma.
    Oncogene. 2007;26:3603-13.
    PubMed     Related articles    Abstract available
    
    
    
23. LEONARD JP , Goldenberg DM
    Preclinical and clinical evaluation of epratuzumab (anti-CD22 IgG) in B-cell malignancies.
    Oncogene. 2007;26:3704-13.
    PubMed     Related articles    Abstract available
    
    
    
24. BONAVIDA B
    Rituximab-induced inhibition of antiapoptotic cell survival pathways: implications in chemo/immunoresistance, rituximab unresponsiveness, prognostic and novel therapeutic interventions.
    Oncogene. 2007;26:3629-36.
    PubMed     Related articles    Abstract available
    
    
    
25. ZHONG Y , Jiang L, Hiai H, Toyokuni S, et al
    Overexpression of a transcription factor LYL1 induces T- and B-cell lymphoma in mice.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
26. NILSSON LM , Keller UB, Yang C, Nilsson JA, et al
    Ink4c is dispensable for tumor suppression in Myc-induced B-cell lymphomagenesis.
    Oncogene. 2007;26:2833-9.
    PubMed     Related articles    Abstract available
    
    
    
27. KAKINUMA S , Kodama Y, Amasaki Y, Yi S, et al
    Ikaros is a mutational target for lymphomagenesis in Mlh1-deficient mice.
    Oncogene. 2007;26:2945-9.
    PubMed     Related articles    Abstract available
    
    
    April 2007
28. HERZIG M , Savarese F, Novatchkova M, Semb H, et al
    Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling.
    Oncogene. 2007;26:2290-8.
    PubMed     Related articles    Abstract available
    
    
    
29. FROST P , Shi Y, Hoang B, Lichtenstein A, et al
    AKT activity regulates the ability of mTOR inhibitors to prevent angiogenesis and VEGF expression in multiple myeloma cells.
    Oncogene. 2007;26:2255-62.
    PubMed     Related articles    Abstract available
    
    
    
30. CHAUHAN D , Velankar M, Brahmandam M, Hideshima T, et al
    A novel Bcl-2/Bcl-X(L)/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma.
    Oncogene. 2007;26:2374-80.
    PubMed     Related articles    Abstract available
    
    
    
31. NANDI S , Reinert LS, Hachem A, Mazan-Mamczarz K, et al
    Phosphorylation of MCT-1 by p44/42 MAPK is required for its stabilization in response to DNA damage.
    Oncogene. 2007;26:2283-9.
    PubMed     Related articles    Abstract available
    
    
    March 2007
32. HABENS F , Lapham AS, Dallman CL, Pickering BM, et al
    Distinct promoters mediate constitutive and inducible Bcl-XL expression in malignant lymphocytes.
    Oncogene. 2007;26:1910-9.
    PubMed     Related articles    Abstract available
    
    
    
33. PARK IW , Reddy MV, Reddy EP, Groopman JE, et al
    Evaluation of novel cell cycle inhibitors in mantle cell lymphoma.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    February 2007
34. KAMRANVAR SA , Gruhne B, Szeles A, Masucci MG, et al
    Epstein-Barr virus promotes genomic instability in Burkitt's lymphoma.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
35. KLEIN E , Kis LL, Klein G
    Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions.
    Oncogene. 2007;26:1297-305.
    PubMed     Related articles    Abstract available
    
    
    
36. BUBMAN D , Guasparri I, Cesarman E
    Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    January 2007
37. WALKER SR , Nelson EA, Frank DA
    STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas.
    Oncogene. 2007;26:224-33.
    PubMed     Related articles    Abstract available
    
    
    December 2006
38. KLUIVER J , van den Berg A, de Jong D, Blokzijl T, et al
    Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available
    
    
    November 2006
39. BROCKE-HEIDRICH K , Ge B, Cvijic H, Pfeifer G, et al
    BCL3 is induced by IL-6 via Stat3 binding to intronic enhancer HS4 and represses its own transcription.
    Oncogene. 2006;25:7297-304.
    PubMed     Related articles    Abstract available
    
    
    
40. MAHTOUK K , Cremer FW, Reme T, Jourdan M, et al
    Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma.
    Oncogene. 2006;25:7180-91.
    PubMed     Related articles    Abstract available
    
    
    
41. MARTINELLI S , Kostylina G, Niggli V, Baumann C, et al
    Targeting survivin via PI3K but not c-akt/PKB by anticancer drugs in immature neutrophils.
    Oncogene. 2006;25:6915-23.
    PubMed     Related articles    Abstract available
    
    
    October 2006
42. STARCZYNOWSKI DT , Trautmann H, Pott C, Harder L, et al
    Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
43. CHEN H , Li M, Campbell RA, Burkhardt K, et al
    Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis.
    Oncogene. 2006;25:6520-7.
    PubMed     Related articles    Abstract available
    
    
    
44. DUAN H , Heckman CA, Boxer LM
    The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
45. NEIMAN PE , Kimmel R, Icreverzi A, Elsaesser K, et al
    Genomic instability during Myc-induced lymphomagenesis in the bursa of Fabricius.
    Oncogene. 2006;25:6325-35.
    PubMed     Related articles    Abstract available
    
    
    
46. PALACIOS G , Moll UM
    Mitochondrially targeted wild-type p53 suppresses growth of mutant p53 lymphomas in vivo.
    Oncogene. 2006;25:6133-9.
    PubMed     Related articles    Abstract available
    
    
    September 2006
47. CHEN E , Kwon YT, Lim MS, Dube ID, et al
    Loss of Ubr1 promotes aneuploidy and accelerates B-cell lymphomagenesis in TLX1/HOX11-transgenic mice.
    Oncogene. 2006;25:5752-63.
    PubMed     Related articles    Abstract available
    
    
    August 2006
48. LEONCINI L , Bellan C, De Falco G
    Retinoblastoma gene family expression in lymphoid tissues.
    Oncogene. 2006;25:5309-14.
    PubMed     Related articles    Abstract available
    
    
    June 2006
49. HOLCOMB VB , Vogel H, Marple T, Kornegay RW, et al
    Ku80 and p53 suppress medulloblastoma that arise independent of Rag-1-induced DSBs.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: